Table 3.
Determinants of adherence level (measured using the Exercise Adherence Rating Scale)
| Univariate | Multivariate* | |||||
| B (SE) | ß | P value | B (SE) | ß | P value | |
| Sociodemographic | ||||||
| Gender (female) | 1.56 (1.01) | 0.14 | 0.153 | |||
| Age (years)† | −0.12 (0.22) | −0.05 | 0.587 | |||
| Satisfaction with economic situation† | −0.01 (0.72) | −0.002 | 0.987 | |||
| Living status (alone)‡ | 2.12 (1.06) | 0.20 | 0.048 | |||
| Years of education‡ | 0.003 (0.11) | 0.003 | 0.978 | |||
| Medical history | ||||||
| Number of medications† | −0.61 (0.21) | −0.29 | 0.003 | −0.45 (0.21) | −0.21 | 0.033 |
| Diagnosed/treated for arthritis§ | −2.10 (1.08) | −0.19 | 0.056 | |||
| Diagnosed/treated for cardiovascular diseases§ | −0.47 (1.30) | −0.04 | 0.721 | |||
| Cognition, affect and well-being | ||||||
| MOCA score‡ | 0.27 (0.27) | 0.10 | 0.337 | |||
| CES-D score‡ | −0.20 (0.08) | −0.25 | 0.011 | −0.20 (0.07) | −0.25 | 0.009 |
| Short Form 12 score‡ | 0.48 (0.17) | 0.28 | 0.006 | |||
| Physical ability and mobility§ | ||||||
| Gait speed, usual pace (4 m walk) | 5.56 (2.29) | 0.24 | 0.017 | |||
| Gait speed, usual pace (7 m walk) | 4.30 (2.02) | 0.21 | 0.036 | |||
| Fast gait speed, fast pace (7 m walk) | 1.82 (1.02) | 0.18 | 0.077 | |||
| CBMS (/96) | 0.11 (0.04) | 0.28 | 0.004 | |||
| 8-Level Balance test (/8)§ | 0.93 (0.52) | 0.18 | 0.077 | |||
| Cadence, mean (SD) | 0.07 (0.11) | 0.07 | 0.517 | |||
| Complexity, mean (SD) | −0.10 (4.13) | −0.002 | 0.981 | |||
| Subjective health rating | ||||||
| Pain while walking, VAS‡ | −0.31 (0.22) | −0.14 | 0.151 | |||
| Pain during rest, VAS ‡ | −0.03 (0.26) | −0.01 | 0.915 | |||
| LLFDI disability frequency (/100) | 0.17 (0.12) | 0.14 | 0.150 | |||
| LLFDI disability limitation (/100) | 0.08 (0.04) | 0.21 | 0.032 | |||
| LLFDI function total (/100) | 0.10 (0.04) | 0.24 | 0.002 | |||
| LLFDI function UE | 0.08 (0.03) | 0.19 | 0.015 | |||
| LLFDI function BLE | 0.09 (0.04) | 0.25 | 0.011 | |||
| LLFDI function ALE | 0.10 (0.03) | 0.28 | 0.004 | |||
| Other potential adherence mediators | ||||||
| Group allocation aLiFE versus eLiFE | −1.45 (1.01) | −0.14 | 0.153 | |||
| Risk screening moderate category | −0.08 (0.02) | −0.03 | 0.006 | −0.06 (0.03) | −0.21 | 0.035 |
Multivariate linear regression (n=120, aLiFE and eLiFE participants).
Bold p<0.05
*Only variables retained in the final model presented.
†Known risk factors for functional decline.
‡Factors which influence adherence.
§Strength and balance deficits known to influence adherence.
ALE, advanced lower extremity; aLiFE, adapted Lifestyle-integrated Functional Exercise; BLE, basic lower extremity; CBMS, Community Balance and Mobility Scale; CES-D, Center for Epidemiological Studies Depression; eLiFE, enhanced Lifestyle-integrated Functional Exercise; LLFDI, Late-Life Function and Disability Index; MOCA, Montreal Cognitive Assessment; UE, upper extremity; VAS, Visual Analogue Scale.